Several companies expected to announce ‘most favored nation’ deals Friday at White Housenews2025-12-17T17:09:17+00:00December 17th, 2025|Endpoints News|
GSK formally submits new leucovorin indication to FDAnews2025-12-17T16:20:50+00:00December 17th, 2025|Endpoints News|
Novo Nordisk hit with FDA warning letter over acquired Catalent factorynews2025-12-17T15:41:07+00:00December 17th, 2025|Endpoints News|
GSK wins FDA approval for long-acting asthma drugnews2025-12-17T00:21:14+00:00December 17th, 2025|Endpoints News|
Pfizer bets big on obesity to offset major patent cliffnews2025-12-16T16:16:07+00:00December 16th, 2025|Endpoints News|
FDA extends decision on Aldeyra’s dry eye disease drugnews2025-12-16T12:14:30+00:00December 16th, 2025|Endpoints News|
Lenz discloses case of retinal tear in presbyopia eye drop patientnews2025-12-15T20:54:37+00:00December 15th, 2025|Endpoints News|
FDA speeds up review of J&J’s multiple myeloma combo treatment following positive datanews2025-12-15T19:25:21+00:00December 15th, 2025|Endpoints News|
Gilead posts second Phase 3 win for new HIV-fighting drug regimennews2025-12-15T17:47:26+00:00December 15th, 2025|Endpoints News|
Immunome’s rare tumor drug passes Phase 3 test, could challenge Merck KGaAnews2025-12-15T15:34:08+00:00December 15th, 2025|Endpoints News|
